FDA: Tattoo inks recalled because they’re contaminated with bacteria

The Food and Drug Administration is recalling tattoo inks for bacterial contamination (Photo: Getty Images/iStockphoto) The Food and Drug Administration announced the recall of six types of tattoo ink because they are contaminated with bacteria. The tattoo inks, made by a handful of manufacturers, are contaminated with microorganisms that can lead to serious injuries and an increased risk of infection since the skin […]

Read more

6 Top Gainers In Pharma Sector (ABIO, PRPO, VCYT…)

The following are some of today’s top gainers in the pharma/biotech sector. 1. ARCA biopharma Inc. (ABIO) ARCA biopharma is a clinical-stage biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases. The Company’s lead product candidate is Gencaro, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). Gencaro is all […]

Read more

Is Relief On The Way For Peanut Allergy?

Peanut allergy, a condition in which the immune system mistakenly recognizes a number of proteins from peanuts as potential foreign pathogens, triggering an inflammation, is most common in children. The rate of peanut allergy is on the rise – with approximately 2 percent of children, roughly 1.5 million children in the U.S., being affected, according to the Jaffe Food Allergy […]

Read more

5 Top Gainers In Healthcare Sector (TMDI, QHC, GH…)

The following are some of today’s top gainers in the pharma/biotech sector. 1. Titan Medical Inc. (TMDI) Titan Medical is a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery. Gained 20.64% to close Wednesday’s (Apr.10) trading at $2.63. News: No news Near-term Catalysts: — Complete the required human […]

Read more

Texas Firm Recalls 3,329 Pounds Of Meat And Poultry Wrap And Salad Products

The U.S. Department of Agriculture’s Food Safety and Inspection Service or FSIS announced that Houston, Texas establishment Great American Marketing, Inc. is recalling approximately 3,329 pounds of ready-to-eat meat and poultry wrap and salad products due to possible Listeria monocytogenes contamination. The problem was discovered when routine testing of a shared FSIS and FDA processing area within the establishment was […]

Read more

5 Top Losers In Healthcare Sector (EVOK, IGXT.OB, APYX…)

The following are some of the pharma/biotech stocks that posted the biggest percentage decline today. 1. Evoke Pharma Inc. (EVOK) Lost 47.06% to close Tuesday’s (Apr.2) trading at $0.90. News: The Company’s investigational drug Gimoti, proposed for the relief of symptoms associated with acute and recurrent diabetic gastroparesis, has been turned down by the FDA. The writing was already written […]

Read more

FDA Schedules First Public Hearing on CBD Rules

Cannabidiol, or CBD, occupies a peculiar space in the U.S. healthcare universe right now. Extract it from the hemp plant, and it's legal. Extract the identical chemical from the closely related marijuana plant, and it's a Schedule I controlled substance. When it's sold by a mainstream pharmaceutical company, after being tested and approved to treat epilepsy, it's a legitimate drug. […]

Read more

ARDS On The Move, GLPG Reports Positive Data, PRTO Plunges On PATENCY-2 Results

Today’s Daily Dose brings you news about Aridis Pharma’s anticipated milestones; Blueprint Medicines’ stock offering; Cardax’s financial results; ESSA Pharma’s progress in prostate cancer program; Gilead Sciences and Galapagos’ Filgotinib trial results; Proteon’s disappointing PATENCY-2 study data and Supernus Pharma’s ADHD trial results. Read on… Aridis Pharmaceuticals Inc. (ARDS) has a couple of catalysts to watch out for in the […]

Read more

Emails show FDA worry with growers after romaine outbreaks

After repeated food poisoning outbreaks tied to romaine lettuce, a U.S. food safety official shared his concerns in an internal email, saying the produce industry's water testing "failed in an epic and tragic way." Continue Reading Below How the industry tests water to grow leafy greens is "unacceptable" and needs to change, James Gorny, a senior adviser for produce safety […]

Read more

Biogen Shares Fall As Late-stage Trials Of Alzheimer’s Drug Discontinued

Shares of Biogen Inc. (BIIB) are falling almost 28 percent in Thursday’s trading after the company and Japanese drugmaker Eisai Co. Ltd. (ESALY.PK) said they will discontinue two late-stage trials for their experimental Alzheimer’s drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate the efficacy and safety of Aducanumab […]

Read more
1 2 3 13